All In MedTech

Device Trial Radar · NCT07335484

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Axonics External Trial System (ETS-02)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Apr 30, 2026

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Axonics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 13, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).

Conditions

  • Urinary Urge Incontinence (UUI)
  • Urinary Frequency (UF)
  • Fecal Incontinence (FI)
  • Overactive Bladder (OAB)

Interventions

  • Axonics External Trial System (ETS)Device

    A temporary electrode wire is passed through the S3 foramen with or without fluoroscopic guidance. The wire is then connected to an external pulse generator (EPG) and is worn for a trial period ranging from 3-7 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall FeasibilityTime frame: Day 5-7
  2. Adverse Events reporting (Safety)Time frame: Day 0-7

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Birmingham, Alabama

    Birmingham, Alabama · Recruiting

  • Atrium Health - Navicent

    Macon, Georgia · Recruiting

  • University of Chicago

    Chicago, Illinois · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.